BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 7, 2007
View Archived Issues
Kosan concludes epothilone agreement with Roche and reveals clinical plans for KOS-1584
Read More
Novel rexinoid compound with promising anticancer activity in experimental breast and lung cancer
Read More
ENMD-1198 metabolism, pharmacokinetics studied in humans
Read More
Escalating doses of CR011-vcMMAE assessed in melanoma patients
Read More
Results of TRITON TIMI-38 trial and plans for TRILOGY ACS trial of prasugrel presented
Read More
Manhattan administers first dose in phase IIa study of topical PTH (1-34) for psoriasis
Read More
FDA approves Oragenics' IND submission for SMaRT Replacement Therapy for tooth decay
Read More
Arete initiates phase I clinical trial of AR-9281 for hypertension
Read More
Neurocrine enters Japanese licensing agreement with Dainippon Sumitomo Pharma for indiplon
Read More
Seattle Genetics initiates phase Ib clinical trial of SGN-40 for multiple myeloma
Read More
Poniard initiates phase II trial of picoplatin for metastatic colorectal cancer
Read More
Progen receives fast track status and plans to initiate phase III trial for PI-88 for liver cancer
Read More
Regado enrolls first patient in phase IIa clinical study of REG-1 anticoagulation system
Read More
FDA grants orphan drug designation to AVI BioPharma's AVI-4658
Read More
Discovery Laboratories formally responds to FDA's April 2006 approvable letter for Surfaxin
Read More
Amira completes phase I trial of AM-103 and initiates phase II trial for AM-803
Read More
Palatin initiates human trials for the treatment of congestive heart failure
Read More
Protox presents positive final data from PRX-302 prostate cancer study
Read More
SkyePharma completes phase III safety study of Flutiform for the treatment of asthma
Read More
Viveta Triumph-1 trial meets primary endpoint
Read More
Positive phase IIa results reported for MEM-3454 in Alzheimer's disease
Read More
Theravance initiates phase II program for MABA compound in COPD
Read More
Recent patents disclose novel agents for metabolic diseases
Read More
Levetiracetam may prevent seizures in Alzheimer's disease patients
Read More
TMC-278 effects on lipids, coadministration with atorvastatin reported
Read More
Studies describe raltegravir resistance, pharmacokinetics, efficacy
Read More
Nicastrin-targeting antibody for cancer and Alzheimer's disease
Read More
NS-4591 shows in vivo activity for the treatment of overactive bladder
Read More
Vernalis presents new FAAH inhibitor with in vivo antinociceptive activity at the SfN meeting
Read More
Preclinical evaluation of Abbott calpain inhibitor points to potential in neurodegenerative disorder
Read More
New treatment option for cachexia disclosed in recent GSK patent
Read More
Novel therapeutics for allergic and respiratory disorders described in recent patents
Read More